Medicare Enrolled
Dr. Peter Hynes, M.D.
Cardiovascular Disease · Sea Girt, NJ
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hynes from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hynes?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hynes
Dr. Peter Hynes is a cardiovascular disease specialist in Sea Girt, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Hynes performed 5,853 Medicare services across 4,505 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hynes received a total of $8,084 from 42 pharmaceutical and/or device companies across 591 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hynes is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in NJ
$8,084 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,853
Medicare services
Top 10% in NJ for cardiovascular disease
4,505
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~308 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,011 | $69 | $106 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
720 | $88 | $147 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
583 | $11 | $19 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
565 | $65 | $90 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
511 | $145 | $285 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
492 | $43 | $75 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
257 | $159 | $243 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
214 | $57 | $168 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
213 | $53 | $83 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
212 | $385 | $557 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
185 | $121 | $192 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
166 | $138 | $231 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
118 | $101 | $162 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
105 | $158 | $233 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
75 | $206 | $295 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
68 | $17 | $31 |
| Ultrasound of brain blood flow An ultrasound test used to evaluate blood flow within the blood vessels of the brain. |
58 | $111 | $152 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
51 | $20 | $35 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts A complete ultrasound exam of the aorta, vena cava, groin vessels, or bypass grafts. This imaging test uses sound waves to visualize these blood vessels. |
46 | $135 | $230 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
32 | $155 | $277 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
30 | $30 | $75 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
22 | $60 | $95 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
18 | $19 | $27 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
18 | $29 | $70 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
18 | $20 | $31 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
15 | $12 | $17 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
14 | $463 | $800 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
14 | $17 | $24 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
11 | $21 | $156 |
| Emergency department visit, moderate complexity An emergency department visit for an established or new patient involving a moderate level of medical decision making. |
11 | $100 | $131 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
12.5% high complexity
28.5% medium
59.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,084
Total received (2018-2024)
Avg $1,155/year across 7 years
Top 25% in NJ for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
591
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,054 (99.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$30 (0.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$416
2023
$1,193
2022
$878
2021
$1,245
2020
$903
2019
$1,419
2018
$2,029
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$230
Boehringer Ingelheim Pharmaceuticals, Inc.
$61
Actelion Pharmaceuticals US, Inc.
$30
AstraZeneca Pharmaceuticals LP
$27
PFIZER INC.
$18
SANOFI-AVENTIS U.S. LLC
$18
Kiniksa Pharmaceuticals International, plc
$17
Novo Nordisk Inc
$15
Top 3 companies account for 77.0% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,271
AstraZeneca Pharmaceuticals LP
$1,203
Novartis Pharmaceuticals Corporation
$1,032
Actelion Pharmaceuticals US, Inc.
$570
E.R. Squibb & Sons, L.L.C.
$451
Boehringer Ingelheim Pharmaceuticals, Inc.
$356
Medtronic Vascular, Inc.
$333
Boston Scientific Corporation
$293
Abbott Laboratories
$285
Amgen Inc.
$254
PFIZER INC.
$222
ABIOMED
$211
BIOTRONIK INC.
$203
Amarin Pharma Inc.
$198
SANOFI-AVENTIS U.S. LLC
$195
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$106
Regeneron Healthcare Solutions, Inc.
$95
CVRx, Inc.
$91
Bayer HealthCare Pharmaceuticals Inc.
$83
Kowa Pharmaceuticals America, Inc.
$83
Kiniksa Pharmaceuticals, Ltd.
$81
Lundbeck LLC
$44
Novo Nordisk Inc
$44
Sensible Medical Innovations Inc
$43
BOSTON SCIENTIFIC CORPORATION
$29
ShockWave Medical, Inc
$29
Siemens Medical Solutions USA, Inc.
$25
Gilead Sciences, Inc.
$24
ARALEZ PHARMACEUTICALS US INC.
$23
Azurity Pharmaceuticals, Inc.
$22
Shockwave Medical, Inc
$20
Tactile Systems Technology Inc
$18
Kiniksa Pharmaceuticals International, plc
$17
Cardiovascular Systems Inc.
$16
G Medical Diagnostic Services, Inc.
$15
Merck Sharp & Dohme Corporation
$15
United Therapeutics Corporation
$14
Horizon Therapeutics plc
$14
Allergan Inc.
$14
Esperion Therapeutics, Inc.
$14
ARBOR PHARMACEUTICALS, INC.
$13
Akcea Therapeutics, Inc.
$12
Top 3 companies account for 43.4% of all-time payments
Associated products mentioned in payments ›
ACUSON SC2000 Diagnostic Ultrasound System · Adempas · Arcalyst · Asahi Fielder coronary guide wire · Azure · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · CARDIOMEMS · Cardiac Monitoring Suite · Circulatory Support · CoreValve Evolut · Corlanor · CryoConsole · ELIQUIS · ENTRESTO · Edarbi · Edarbyclor · Edora · FARXIGA · FLEXITOUCH · GENERAL ATHERECTOMY · Impella · JARDIANCE · KRYSTEXXA · LEQVIO · LifeVest · Livalo · MITRACLIP · MULTAQ · Micra · MitraClip System · NEXLETOL · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RESONATE · ReDS system · Repatha · Rivacor · Rybelsus · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · TEGSEDI · UPTRAVI · VERQUVO · VIGILANT · VYNDAQEL · Vascepa · WATCHMAN · WATCHMAN Access System · XARELTO · Xience Alpine cornary stent system · Xience cornary stent systems · ZONTIVITY
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
123
Per 100K population
19.1
County median income
$122,727
Nearest hospital
OCEAN MEDICAL CENTER
4.8 mi
4.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hynes is a clinical cardiology specialist, with above-average Medicare volume (top 10% in NJ), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hynes experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Hynes performed 1,011 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hynes receive payments from pharmaceutical companies?
Yes. Dr. Hynes received a total of $8,084 from 42 companies across 591 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hynes's costs compare to other cardiologists in Sea Girt?
Dr. Hynes's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hynes) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Sea Girt
Browse cardiologists in Sea Girt ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in NJ
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in NJ
Which NJ cardiologists receive the most from drug and device companies.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology